Stockscreener 앱 받기
0.00
0.00%
0.00
Vitro Biopharma, Inc. 주식(VTRO)의 최신 뉴스
Best Biotech Stocks of 2026 and How to Invest in Them - The Motley Fool
Reviewing Rein Therapeutics (NASDAQ:RNTX) and Vitro Diagnostics (OTCMKTS:VODG) - Defense World
Financial Contrast: Imunon (NASDAQ:IMNN) vs. Vitro Diagnostics (OTCMKTS:VODG) - Defense World
What Stem Cell Clinics Do You Trust? - BioInformant
Vitro Biopharma Receives ISO 13485 Certification Supporting its Stem Cell Medical Tourism Initiative - ACCESS Newswire
Vitro Biopharma Retains Leading Health Care Executive as Acting Director of Regulatory Affairs & Director - ACCESS Newswire
10 cultured meat companies driving sustainable food in 2025 - Labiotech.eu
Vitro Biopharma's AlloRx Stem Cell TherapyFeatured in New York Times Article on Health Secretary Kennedy's, Vision for Expanding Access to Regenerative Medicine - ACCESS Newswire
Vitro Biopharma's AlloRx Stem Cell Therapy Featured in New York Times Article on Health Secretary Kennedy's Vision for Expanding Access to Regenerative Medicine - ACCESS Newswire
Vitro Biopharma Receives FDA Authorization to Conduct a Clinical Trial Using AlloRx Stem Cells(R) to Treat COVID-19 - ACCESS Newswire
Be Biopharma to Present at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting - CRISPR Medicine News
Dealmaking Quarterly Statistics, Q4 2024 - Citeline News & Insights
Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner - Business Wire
In Vitro Diagnostics (IVD) Market Size to Surpass USD 157.56 Billion by 2034 - BioSpace
Swiss biotech going strong in 2024: 18 companies to put on your radar - Labiotech.eu
Dealmaking Quarterly Statistics, Q2 2022 - insights.citeline.com
Top 5 In-Vitro Diagnostics [IVD] Companies, Worldwide by 2024 - Fortune Business Insights
A biotech working on a new approach to IVF raises $33M in fresh funding - BioPharma Dive
New In Vitro Data Showing Matinas BioPharma’s LNC Platform - GlobeNewswire
GenScript Biotech Corporation Announces Self-Amplifying RNA Synthesis Service for Advanced Therapeutic Applications - BioSpace
FDA defends lab test rule, as critics fear industry upheaval - BioPharma Dive
ProteoMixture: A cell type deconvolution tool for bulk tissue proteomic data - ScienceDirect.com
Vitro Biopharma adds Crown Resorts legal, compliance chief to board - Compliance Week
SIRION Biotech - Pharmaceutical Technology
Vitro Biopharma Announces Thomas Ohrt New Chief Financial Officer - MarketScreener
Vitro Biopharma, Inc. Announces Chief Financial Officer Changes - marketscreener.com
Kirk Cousins travels to Caribbean for stem cell treatment - kare11.com
Tickers - Finansavisen
In Vitro Fertilization (IVF) Market Size & Share to Surpass $1296.47 Mn by 2030 | Vantage Market Research - Yahoo Finance
IPO Update: Vitro Biopharma Aims For $10 Million U.S. IPO (VTRO) - Seeking Alpha
VTRO IPO NewsStem cell biotech Vitro Biopharma sets terms for $10 million IPO - renaissancecapital.com
Global Stem Cells Market Research Report 2023: Implications - GlobeNewswire
Vitro Biopharma, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
GT Biopharma Poster Presentation and Mini Oral Session at - GlobeNewswire
Vitro Biopharma Names Chris Furman Chief Executive Officer - Yahoo Finance
Business of Biotechniques 2022 - BioTechniques
Regen BioPharma, Inc. Announces Signing of a Letter of Intent to Acquire an In vitro Diagnostics Start-Up Company Canary Oncoceutics, Inc. Which is Developing Functional Cancer Tests for Personalized Medicine - Stock Titan
Developing A Robust In Vitro Intestinal Model For Preclinical Candidate Screening Of GI Toxicity - Pharmaceutical Online
User - FinancialContent
Vitro Biopharma Receives FDA Authorization to Conduct a Clinical Trial Using AlloRx Stem Cells® to Treat COVID-19 - BioInformant
DVC Stem: Stem Cell Therapy Clinic in the Cayman Islands - BioInformant
In vitro glycoengineeringSuitability for BioPharma manufacturing - Labroots
Critically Ill COVID-19 Patient Successfully Treated with Vitro Biopharma’s AlloRx Stem Cells(R) - BioInformant
Vor Biopharma Raises $110M to Develop Engineered Hematopoietic Stem Cells - BioInformant
Vitro Bio-Pharma 2nd Quarter Ended April 30th 2020 Financial Results of Operations and Shareholder Letter - ACCESS Newswire
VODG), dba Vitro Biopharma, announced its 2nd quarter ended April 30 th 2019 financial results of operations. - SEC.gov
Fujifilm Acquiring Irvine Scientific, IS Japan for $800M, with Cell Culture Media Growth in MindGEN - GEN - Genetic Engineering and Biotechnology News
Global Stem Cell Technologies and Applications Market 2018-2018Visiongain Report - PR Newswire UK
Here Are the Top 10 In Vitro Diagnostic Companies - BioSpace
Merck KGaA debuts new fertility tech division - BioPharma Dive
Vitro Diagnostics (VODG) Stock Price, News & Analysis - MarketBeat
Bacillus-derived Hyaluronic acid from Novozymes Biopharma, Hyasis®, increases in vitro drug release time from under 10 minutes to approximately 15 hours - News-Medical
VODG Logo - Cision News
1.24%
0.19%
자본화:
|
볼륨(24시간):